Browse CATs

Browse CATs  internal medicine  cardiology  deep vein thrombosis

Diagnosis Economics Harm/ aetiology Prognosis Therapy Heparin Warfarin Prophylaxis

Deep vein thrombosis no clear difference between anticoagulation started at home or in hospital Level of evidence 1b- Expiry Date November 2003 Deep vein thrombosis no clear difference between nadroparin and acenocoumarol long-term Level of evidence 1b Expiry Date November 2003 Deep vein thrombosis calf: three months of anticoagulation reduced recurrences. Level of evidence 1b Expiry Date March 2003 Venous thromboembolism vitamin K antagonists reduce recurrent episodes, but the benefits decrease over time Level of evidence 1a Expiry Date November 2003 Deep vein thrombosis three months anticoagulation was not clearly better than four weeks Level of evidence 1b- Expiry Date May 2003 Deep vein thrombosis first episode: fewer recurrences occurred on six months of warfarin compared with six weeks. Level of evidence 1b Expiry Date September 2003 Venous thromboembolism three months of anticoagulation may be safer than four weeks. Level of evidence 1b Expiry Date May 2003 Venous thromboembolism idiopathic: indefinite anticoagulation reduced recurrent episodes. Level of evidence 1b Expiry Date October 2003 Venous thromboembolism indefinite warfarin decreased recurrence. Level of evidence 1b Expiry Date May 2003